Novo Nordisk Seeks to Expand Liver Disease Treatments in $5.2B Deal for Bay Area Biotech
Novo Nordisk has reshaped countless waistlines. Now the Ozempic maker is aiming a little higher in the abdomen. The Danish...
Area
Fangzhou Launches Partnership for “AI + Hepatitis Prevention & Control Training Center” at the Greater Bay Area International Liver Disease Forum
GUANGZHOU, China, April 16, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven healthcare solutions,...
